Register
Login:
Share:
Email Facebook Twitter




SAR Share Chat - RSS Feed

Sareum Share Chat (SAR)



Share Price: 0.35Bid: 0.30Ask: 0.40Change: 0.00 (0.00%)No Movement on Sareum
Spread: 0.10Spread as %: 33.33%Open: 0.35High: 0.35Low: 0.325Yesterday’s Close: 0.35


Share Discussion for Sareum (SAR)


Thread ViewThread View
Please Login or Register to post messages
Posts per page:


Premium Membership
Mrsape
Posts: 23
Off Topic
Opinion:No Opinion
Price:0.48
hmmmmm
9 May '14
so the price action suggests worries about dilution.
however IMHO. the lack of newsflow is reason for optmism. I have a strong belief discussions are underway (but no evidence apart from lack of news)
 
50sBoy
Posts: 341
Off Topic
Opinion:No Opinion
Price:0.48
anticipation
9 May '14
I would expect a little upwards movement this afternoon in anticipation of good news.
Hopkirk
Posts: 1,221
Off Topic
Opinion:No Opinion
Price:0.48
Mrsape
9 May '14
Welcome back.

Whats your opinion on CHK1 Phase 1 costs? The same as BACIT or something more complicated?
Mrsape
Posts: 23
Off Topic
Opinion:No Opinion
Price:0.48
back
9 May '14
not posted for a year.
back time. feeling we are about to rocket.
Pfizer/ AZN uncertainty interesting. can see a bit more research money and attention coming our way (ICR/ CRT etc) pending the dust settling.

GLA
50sBoy
Posts: 341
Off Topic
Opinion:No Opinion
Price:0.48
Hopkirk
8 May '14
Thanks
Always good to read success stories like that.
Hopkirk
Posts: 1,221
Off Topic
Opinion:No Opinion
Price:0.48
PCS / 50sBoy
8 May '14
The quiet period won't last but always nice to discuss the possibilities.

50sBoy. Anything is possible with funding but if someone were to pay SARs share, they would want something in return.

And just noticed this. Not SAR specific but nice background on the oncology sector, ALL (which is one of the leukaemias Aurora FLT3 is going after), immunotherapy (not measles unfortunately) but some very nice, big numbers.

We all know its high risk, but this shows what some of the rewards could be

http://www.forbes.com/sites/matthewherper/2014/05/07/is-this-how-well-cure-cancer/
PCS1954
Posts: 1,022
Off Topic
Opinion:No Opinion
Price:0.48
View Thread (2)
RE: PCS1954
8 May '14
Hopkirk Evening good to see a chatty bb - my point entirely if things are looking positive then Sar should be saying we have the "cake" who wants a bite because we are adding a layer, unless TM has locked into a "rolling contract", which will be somewhat disappointing if the product is improving and the finance from outside isn't.

Anyway, as you said lots of possibilities.......and so far science has been good!!

GLA
50sBoy
Posts: 341
Off Topic
Opinion:No Opinion
Price:0.48
Good reading tonight
8 May '14
I confess i know very little as to raising funds in these situations, but i would think this was all through well through before arriving where we are today.
Hopkirk, can't remember if you corrected me on this before, but isn't it possible that a backer may pay what ever is needed on behalf of Sar, or is that not possible........my thoughts only
Hopkirk
Posts: 1,221
Off Topic
Opinion:No Opinion
Price:0.48
Enlightened
8 May '14
The SEDA is just a smaller version of a placing. Same impact (dilution / shares placed at a discount) but it has a maximum amount that can be drawn down in a given period. So for large cash calls, its got to be a placing but its good for working capital purposes (until the revenue starts to roll in!).

The cash burn rate (from memory) has been fairly static at about 50k to 55k a month for the past couple of years. The placing RNS said this was enough to cover normal requirements (the 800k ws an exceptional one off requirement) and would last up to about early 2015. But it did say something about this not covering any potential "further financial commitments" relating to CHK1. Now this could be an expanded pre clinical dwvelopment involving MV-NIS or the cost of Phase1.

And Tim has seemed to draw down (SEDA or placings) when there has been about 3 to 4 months cash left in the bank in the past.

I believe you need to show that you have the funds needed to conduct the trials before approval is granted. My guess is that if a placing is needed it isn't imminent - probably from September onwards at a guess, so still time for something else to happen.

All IMO. GLA
Hopkirk
Posts: 1,221
Off Topic
Opinion:No Opinion
Price:0.48
View Thread (2)
PCS1954
8 May '14
Hi. True. Maybe BACIT will pay the lions share reducing SARs fundraising requirements but my suspicion is that its all equal and any reduction of payments at this stage might result in a smaller share of any deal for CHK1 in the future. SAR could have walked away at the BACIT / CPF deal stage but decided to stay on and pay the 800k and I suspect the payments will be equal in return for equal rewards.

Aurora + FLT3 is a different story. Both are due to start at the end of this year / early next year but from the timescales I've read, it takes much longer for Chinese approval. So I would expect news on this front before CHK1. That should lift the share price too, helping with any possible funding requirements (if needed).

There are lots of possibilities. It will only take one to either get a deal or make it to human trials for the future to look much brighter. And lets not forget, its the science that will be the deciding factor and so far all of the science over the last few years had been good.

Long may that continue





Sign up for Live Prices


Home  |  Contact Us  |  About Us  |  Careers  |  Advertise with Us  |  Sitemap  |  Terms & Conditions  |  Cookies  |  Privacy


Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.